These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35917732)

  • 1. A comprehensive forced degradation studies of Cariprazine hydrochloride using LC-HRMS/MS and in silico toxicity predictions of its degradation products.
    Jain M; Khan S
    J Pharm Biomed Anal; 2022 Sep; 219():114955. PubMed ID: 35917732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LC/Q-TOF-MS-based structural characterization of enasidenib degradation products and establishment of a stability-indicating assay method: Insights into chemical stability.
    Chakkar A; Chaturvedi S; Rajput N; Sengupta P; Sharma N
    Rapid Commun Mass Spectrom; 2024 Mar; 38(5):e9696. PubMed ID: 38355880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LC and LC-MS/MS studies for identification and characterization of new degradation products of ibrutinib and elucidation of their degradation pathway.
    Mehta L; Naved T; Grover P; Bhardwaj M; Mukherjee D
    J Pharm Biomed Anal; 2021 Feb; 194():113768. PubMed ID: 33279300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Method validation and characterization of stress degradation products of azelastine hydrochloride using LC-UV/PDA and LC-Q/TOF-MS studies.
    Shekhar S; Bali A
    Rapid Commun Mass Spectrom; 2024 Apr; 38(7):e9712. PubMed ID: 38351666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of stress degradation products of febuxostat employing ultra-performance liquid chromatography-ultraviolet/photodiode array and liquid chromatography-mass spectrometry/time-of-flight studies.
    Saha M; Bali A; Patra SR; Singh J
    Rapid Commun Mass Spectrom; 2023 Jan; 37(2):e9423. PubMed ID: 36278931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a stability-indicating high performance liquid chromatographic assay for determination of cariprazine in bulk form and in drug product.
    Toujani E; Mejri W; Lassoued HE; Toujani S; Fliss O; Cheikh MHB; Safta F
    Ann Pharm Fr; 2023 Jan; 81(1):83-93. PubMed ID: 36037933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of stress degradation products of duloxetine hydrochloride employing LC-UV/PDA and LC-MS/TOF studies.
    Chadha R; Bali A; Bansal G
    J Pharm Biomed Anal; 2016 Mar; 121():39-55. PubMed ID: 26775018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of forced degradation products of sertraline hydrochloride using UPLC, ultra-high-performance liquid Chromatography-Quadrupole-Time of flight mass spectrometry (UHPLC-Q-TOF/MS/MS) and NMR.
    Grover P; Bhardwaj M; Mukherjee D
    J Pharm Biomed Anal; 2022 Nov; 221():115045. PubMed ID: 36126615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of major degradation products of Eprinomectin drug substance including degradation pathways using LC-HRMS and NMR.
    Adhikari S; Rustum AM
    J Pharm Biomed Anal; 2022 Jun; 215():114767. PubMed ID: 35447491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validated stability indicating assay method of olaparib: LC-ESI-Q-TOF-MS/MS and NMR studies for characterization of its new hydrolytic and oxidative forced degradation products.
    Thummar M; Kuswah BS; Samanthula G; Bulbake U; Gour J; Khan W
    J Pharm Biomed Anal; 2018 Oct; 160():89-98. PubMed ID: 30075398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LC and LC-MS/MS studies for identification and characterization of degradation products of d-tubocurarine chloride.
    Grover P; Maheshwari S; Nagarajan K; Mehta L; Kumar S; Rastogi C
    J Pharm Biomed Anal; 2023 Jan; 223():115119. PubMed ID: 36343537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of degradation products of macitentan under various stress conditions using liquid chromatography/mass spectrometry.
    Yerra NV; Pallerla P; Pandeti S; Tabet JC; Thota JR
    Rapid Commun Mass Spectrom; 2018 Jul; 32(13):1075-1084. PubMed ID: 29660192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the forced degradation behavior of prasugrel hydrochloride by liquid chromatography with mass spectrometry and liquid chromatography with NMR detection and prediction of the toxicity of the characterized degradation products.
    Singh DK; Sahu A; Handa T; Narayanam M; Singh S
    J Sep Sci; 2015 Sep; 38(17):2995-3005. PubMed ID: 26114771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of urapidil stress degradation products by LC-Q-TOF-MS and NMR: Toxicity prediction of degradation products.
    Velip L; Dhiman V; Kushwah BS; Golla VM; Gananadhamu S
    J Pharm Biomed Anal; 2022 Mar; 211():114612. PubMed ID: 35101803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation kinetics and characterization of major degradants of binimetinib employing liquid chromatography-high resolution mass spectrometry.
    Rajput N; Soni F; Sahu AK; Jadav T; Sharma S; Sengupta P
    J Pharm Biomed Anal; 2022 Jun; 215():114753. PubMed ID: 35447490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural characterization and in silico toxicity prediction of degradation impurities of roxadustat.
    Mahajan R; Kumar S; Parupalli R; Khemchandani R; Kanchupalli V; Nanduri S; Samanthula G; Asthana A
    J Pharm Biomed Anal; 2023 Sep; 234():115517. PubMed ID: 37320975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on the hydrolytic degradation behaviour of bictegravir by LC-PDA-Q/TOF-MS/MS NMR and in silico toxicity assessment.
    Dannarm SR; Harini D; Reddy GN; Ali N; Sonti R
    J Pharm Biomed Anal; 2024 Feb; 239():115909. PubMed ID: 38104374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive study to identify and characterize major degradation products of Ivermectin drug substance including its degradation pathways using LC-HRMS and NMR.
    Adhikari S; Rustum AM
    J Pharm Biomed Anal; 2022 May; 214():114730. PubMed ID: 35334396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress degradation studies on lornoxicam using LC, LC-MS/TOF and LC-MSn.
    Modhave DT; Handa T; Shah RP; Singh S
    J Pharm Biomed Anal; 2011 Nov; 56(3):538-45. PubMed ID: 21757313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into the degradation chemistry of tazarotene, a third generation acetylenic retinoid: LC-HRMS (Orbitrap), LC-MS
    Singh DK; Sahu A; Balhara A; Giri S; Singh S
    J Pharm Biomed Anal; 2020 Jul; 186():113316. PubMed ID: 32413825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.